ALEJANDRO J MIRANDA-SOUSA M.D. NPI 1639283534

NPI Details

Alejandro J Miranda-sousa, M.D. is an urology in Fort Myers, FL with 29 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Alejandro J Miranda-sousa, M.D. NPI is 1639283534. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

4571 COLONIAL BLVD STE 110
FORT MYERS, FL
ZIP 33966-156
Phone: (239) 226-2727
Fax: (239) 939-9876

The NPI 1639283534 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Bcg live intravesical instillation, 1 mg (HCPCS:J9030)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Bacterial colony count, urine (HCPCS:87086)
• Biofeedback training for bowel or bladder control, initial 15 minutes (HCPCS:90912)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Bacterial urine culture (HCPCS:87088)
• Tissue marker, implantable, any type, each (HCPCS:A4648)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Biopsy of prostate gland (HCPCS:55700)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Study of rectum sensitivity and function (HCPCS:91122)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Assessment of muscle signal of pelvic nerves (HCPCS:51792)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Injection of biodegradable material next to prostate (HCPCS:55874)
• Placement of device in prostate for radiation therapy (HCPCS:55876)
• Insertion of temporary bladder tube (HCPCS:51701)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm (HCPCS:52235)
• Instillation of anti-cancer drug into bladder (HCPCS:51720)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm (HCPCS:52224)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm (HCPCS:52234)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 8/18/2006 and was last updated on 3/9/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.